• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000-2010 年法国肺栓塞死亡率的时间趋势。

Time trends in pulmonary embolism mortality in France, 2000-2010.

机构信息

Department of Chronic Diseases and Injuries, French Institute for Public Health Surveillance, Saint Maurice, France.

Department of Chronic Diseases and Injuries, French Institute for Public Health Surveillance, Saint Maurice, France.

出版信息

Thromb Res. 2015 Feb;135(2):334-8. doi: 10.1016/j.thromres.2014.12.002. Epub 2014 Dec 5.

DOI:10.1016/j.thromres.2014.12.002
PMID:25511577
Abstract

BACKGROUND

Pulmonary Embolism (PE) is a potentially fatal complication of venous thrombosis. Recent and comprehensive estimates of PE incidence and mortality are scarce. Moreover, while contemporary mortality trends of PE would enable the evaluation of prevention and quality of care, such data are lacking. The aim of this study was to provide nationwide estimations of PE mortality and time trends in France between 2000 and 2010.

METHODS

Mortality data were obtained from the French Epidemiology Center on medical causes of death. Mortality rates were calculated with PE as an underlying or one of multiple causes of death. The annual percentage changes were assessed using a Poisson regression model. Age-standardized PE mortality rates were also assessed.

RESULTS

In 2010, the overall age-adjusted PE mortality rate was 21.0 per 100000. This rate was 30% higher in men than in women and decreased by 3% per year between 2000 and 2010. Over this period, PE mortality declined in men and women over 55 years but only slightly decreased in patients younger than 55. Cancer, obesity, osteopathies and complications of surgery were often coded as the underlying causes of death when PE was an associated cause of death recorded on certificate.

DISCUSSION

This study is the first to provide a contemporary and exhaustive nationwide estimation of PE mortality and time trends in France. The observed decrease in PE mortality between 2000 and 2010 is encouraging, but further efforts in prevention are needed to ensure that this reduction is widespread in all age groups.

摘要

背景

肺栓塞(PE)是静脉血栓形成的一种潜在致命并发症。目前缺乏对 PE 发病率和死亡率的最新和全面估计。此外,虽然当代 PE 死亡率趋势可以评估预防和护理质量,但缺乏此类数据。本研究旨在提供法国 2000 年至 2010 年期间全国范围内的 PE 死亡率和时间趋势估计。

方法

死亡率数据来自法国流行病学中心的死因医学数据。死亡率计算以 PE 作为根本或多种死因之一。使用泊松回归模型评估年百分比变化。还评估了年龄标准化的 PE 死亡率。

结果

2010 年,总体年龄调整后的 PE 死亡率为 21.0/100000。男性的这一比率比女性高 30%,2000 年至 2010 年间每年下降 3%。在此期间,55 岁以上男性和女性的 PE 死亡率下降,但 55 岁以下患者的死亡率略有下降。癌症、肥胖症、整骨疗法和手术并发症通常被编码为 PE 作为相关死因记录在死亡证明上时的根本死因。

讨论

本研究首次提供了法国当代和全面的 PE 死亡率和时间趋势的估计。2000 年至 2010 年间观察到的 PE 死亡率下降令人鼓舞,但仍需进一步努力预防,以确保这种减少在所有年龄组中广泛发生。

相似文献

1
Time trends in pulmonary embolism mortality in France, 2000-2010.2000-2010 年法国肺栓塞死亡率的时间趋势。
Thromb Res. 2015 Feb;135(2):334-8. doi: 10.1016/j.thromres.2014.12.002. Epub 2014 Dec 5.
2
Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018.1999 年至 2018 年美国肺栓塞死亡率的时间趋势。
J Am Heart Assoc. 2020 Sep;9(17):e016784. doi: 10.1161/JAHA.120.016784. Epub 2020 Aug 17.
3
Trends in death attributed to myocardial infarction, heart failure and pulmonary embolism in Europe and Canada over the last decade.过去十年中欧洲和加拿大归因于心肌梗死、心力衰竭和肺栓塞的死亡趋势。
QJM. 2014 Oct;107(10):813-20. doi: 10.1093/qjmed/hcu083. Epub 2014 Apr 11.
4
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy.意大利西北部 11 年观察期内住院治疗肺栓塞的时间趋势和病死率。
Thromb Haemost. 2016 Jan;115(2):399-405. doi: 10.1160/TH15-02-0172. Epub 2015 Sep 17.
5
Trends in pulmonary embolism morbidity and mortality in Australia.澳大利亚肺栓塞发病率和死亡率趋势。
Thromb Res. 2013 Jul;132(1):19-25. doi: 10.1016/j.thromres.2013.04.032. Epub 2013 May 29.
6
Pregnancy-related deaths due to pulmonary embolism in Sweden.瑞典因肺栓塞导致的与妊娠相关的死亡。
Acta Obstet Gynecol Scand. 2007;86(4):435-43. doi: 10.1080/00016340701207500.
7
Hospital mortality due to pulmonary embolism and an evaluation of the usefulness of preventative interventions.因肺栓塞导致的医院死亡率,以及预防干预措施的有效性评估。
Thromb Res. 2010 Feb;125(2):166-70. doi: 10.1016/j.thromres.2009.06.025. Epub 2009 Jul 31.
8
Pulmonary Embolism Mortality in Brazil from 1989 to 2010: Gender and Regional Disparities.1989年至2010年巴西的肺栓塞死亡率:性别和地区差异
Arq Bras Cardiol. 2016 Jan;106(1):4-12. doi: 10.5935/abc.20160001. Epub 2015 Nov 10.
9
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database.2000-2018 年美国和加拿大与肺栓塞相关的年龄性别特异性死亡率:对世界卫生组织死亡率数据库和疾病预防控制中心多死因数据库的分析。
Lancet Respir Med. 2021 Jan;9(1):33-42. doi: 10.1016/S2213-2600(20)30417-3. Epub 2020 Oct 12.
10
[An update on pulmonary embolism-related mortality in Italy (2003-2015)].[意大利肺栓塞相关死亡率的最新情况(2003 - 2015年)]
G Ital Cardiol (Rome). 2020 Aug;21(8):639-646. doi: 10.1714/3405.33898.

引用本文的文献

1
Global trends in mortality related to pulmonary embolism: an epidemiological analysis of data from the World Health Organization mortality database from 2001 to 2023.与肺栓塞相关的全球死亡率趋势:对世界卫生组织2001年至2023年死亡率数据库数据的流行病学分析
EClinicalMedicine. 2025 Jul 31;86:103389. doi: 10.1016/j.eclinm.2025.103389. eCollection 2025 Aug.
2
Effects on mortality of extended versus short-term anticoagulation in venous thromboembolism: a systematic review and meta-analysis of randomized trials.静脉血栓栓塞症中延长抗凝与短期抗凝对死亡率的影响:一项随机试验的系统评价和荟萃分析
Res Pract Thromb Haemost. 2025 Jun 9;9(4):102928. doi: 10.1016/j.rpth.2025.102928. eCollection 2025 May.
3
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.
性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.
4
Prevalence and clinical characteristics of venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis.肺癌患者静脉血栓栓塞症的患病率及临床特征:一项系统评价和荟萃分析。
Front Oncol. 2024 Aug 14;14:1405147. doi: 10.3389/fonc.2024.1405147. eCollection 2024.
5
Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis.首次发生肺栓塞或深静脉血栓形成后与人群对照相比的时间趋势和超额死亡率
Thromb Haemost. 2025 Apr;125(4):364-375. doi: 10.1055/a-2402-6192. Epub 2024 Aug 23.
6
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease.加菲猫静脉血栓栓塞症(GARFIELD-VTE)研究中维生素K拮抗剂与直接口服抗凝剂的治疗期比较疗效,重点关注癌症和肾脏疾病。
TH Open. 2022 Nov 3;6(4):e354-e364. doi: 10.1055/s-0042-1757744. eCollection 2022 Oct.
7
Trends in Mortality Due to Myocardial Infarction, Stroke, and Pulmonary Embolism in Patients Receiving Dialysis.透析患者心肌梗死、卒中和肺栓塞死亡率的变化趋势。
JAMA Netw Open. 2022 Apr 1;5(4):e227624. doi: 10.1001/jamanetworkopen.2022.7624.
8
Prognosis and risk factors in older patients with lung cancer and pulmonary embolism: a propensity score matching analysis.老年肺癌合并肺栓塞患者的预后和危险因素:倾向评分匹配分析。
Sci Rep. 2020 Jan 27;10(1):1272. doi: 10.1038/s41598-020-58345-4.
9
Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism.接受长期维生素K拮抗剂或直接口服抗凝剂治疗静脉血栓栓塞的患者的生活质量评估、抗凝治疗满意度及治疗依从性
Patient Prefer Adherence. 2017 Sep 25;11:1625-1634. doi: 10.2147/PPA.S131157. eCollection 2017.
10
Thrombosis Related , , and Gene Polymorphisms in Morbidly Obese Patients.肥胖症患者中与血栓形成相关的、、和基因多态性
Dis Markers. 2016;2016:7853424. doi: 10.1155/2016/7853424. Epub 2016 Nov 23.